{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:04:07Z","timestamp":1740146647957,"version":"3.37.3"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"the National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2017R1E1A1A01074298"],"award-info":[{"award-number":["NRF-2017R1E1A1A01074298"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002380","name":"Hanyang University","doi-asserted-by":"publisher","award":["HY-201900000002619"],"award-info":[{"award-number":["HY-201900000002619"]}],"id":[{"id":"10.13039\/501100002380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0238078","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T17:32:27Z","timestamp":1598463147000},"page":"e0238078","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma"],"prefix":"10.1371","volume":"15","author":[{"given":"Jihyun","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5471-7790","authenticated-orcid":true,"given":"Ha Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seheon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7336-1371","authenticated-orcid":true,"given":"Ju Hyun","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"pone.0238078.ref001","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"J Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"pone.0238078.ref002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.510290145","article-title":"Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials","volume":"29","author":"JM Llovet","year":"1999","journal-title":"Hepatology"},{"key":"pone.0238078.ref003","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005","volume":"27","author":"SF Altekruse","year":"2009","journal-title":"J Clin Oncol"},{"key":"pone.0238078.ref004","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2016.07.025","article-title":"Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort","volume":"65","author":"S Mittal","year":"2016","journal-title":"J Hepatol"},{"key":"pone.0238078.ref005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/gutjnl-2014-308786","article-title":"Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study","volume":"65","author":"CY Wu","year":"2016","journal-title":"Gut"},{"key":"pone.0238078.ref006","article-title":"Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis","author":"K Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"pone.0238078.ref007","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","article-title":"Phases of biomarker development for early detection of cancer","volume":"93","author":"MS Pepe","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"pone.0238078.ref008","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update","volume":"53","author":"J Bruix","year":"2011","journal-title":"Hepatology"},{"key":"pone.0238078.ref009","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2009.04014.x","article-title":"Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis","volume":"30","author":"A Singal","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0238078.ref010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The L, European Organisation For R, Treatment Of C","year":"2012","journal-title":"J Hepatol"},{"key":"pone.0238078.ref011","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cld.2015.01.005","article-title":"Elevated alpha-fetoprotein: differential diagnosis\u2014hepatocellular carcinoma and other disorders","volume":"19","author":"RJ Wong","year":"2015","journal-title":"Clin Liver Dis"},{"key":"pone.0238078.ref012","article-title":"Aasld guidelines for the treatment of hepatocellular carcinoma","author":"J Heimbach","year":"2017","journal-title":"Hepatology"},{"key":"pone.0238078.ref013","doi-asserted-by":"crossref","first-page":"563","DOI":"10.6004\/jnccn.2017.0059","article-title":"NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017","volume":"15","author":"AB, 3rd Benson","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"pone.0238078.ref014","article-title":"A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis","volume":"146","author":"HB El-Serag","year":"2014","journal-title":"Gastroenterology"},{"key":"pone.0238078.ref015","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1053\/j.gastro.2015.10.004","article-title":"The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection with Hepatitis C Virus-Related Cirrhosis","volume":"149","author":"DL White","year":"2015","journal-title":"Gastroenterology"},{"key":"pone.0238078.ref016","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"JM Llovet","year":"2002","journal-title":"The Lancet"},{"key":"pone.0238078.ref017","first-page":"267","article-title":"2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma","volume":"9","author":"Korean Liver Cancer Study G, National Cancer Center K","year":"2015","journal-title":"Gut Liver"},{"key":"pone.0238078.ref018","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/clinchem\/31.11.1868","article-title":"Evaluation of a commercial immunoenzymometric assay for alpha-fetoprotein","volume":"31","author":"DA Hullin","year":"1985","journal-title":"Clin Chem"},{"key":"pone.0238078.ref019","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ajg.2012.449","article-title":"Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?","volume":"108","author":"AG Singal","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"pone.0238078.ref020","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ajg.2015.100","article-title":"Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis","volume":"110","author":"T-S Chang","year":"2015","journal-title":"The American journal of gastroenterology"},{"key":"pone.0238078.ref021","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/hep.28895","article-title":"An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"65","author":"O Atiq","year":"2017","journal-title":"Hepatology"},{"key":"pone.0238078.ref022","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC Cancer Staging Manual","author":"ME Amin","year":"2017","edition":"8"},{"key":"pone.0238078.ref023","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4258\/hir.2013.19.2.102","article-title":"Lessons Learned from Development of De-identification System for Biomedical Research in a Korean Tertiary Hospital","volume":"19","author":"SY Shin","year":"2013","journal-title":"Healthc Inform Res"},{"key":"pone.0238078.ref024","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/sim.5705","article-title":"The performance of different propensity score methods for estimating marginal hazard ratios","volume":"32","author":"PC Austin","year":"2013","journal-title":"Stat Med"},{"key":"pone.0238078.ref025","doi-asserted-by":"crossref","first-page":"467428","DOI":"10.1155\/2013\/467428","article-title":"The MATCHIT automaton: exploiting compartmentalization for the synthesis of branched polymers","volume":"2013","author":"MS Weyland","year":"2013","journal-title":"Comput Math Methods Med"},{"key":"pone.0238078.ref026","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/1097-0142(196111\/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H","article-title":"A biomathematical approach to clinical tumor growth","volume":"14","author":"M Schwartz","year":"1961","journal-title":"Cancer"},{"key":"pone.0238078.ref027","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1478-3231.2007.01576.x","article-title":"Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis","volume":"28","author":"GL Wong","year":"2008","journal-title":"Liver Int"},{"key":"pone.0238078.ref028","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0016-5085(85)90324-5","article-title":"Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications","volume":"89","author":"JC Sheu","year":"1985","journal-title":"Gastroenterology"},{"key":"pone.0238078.ref029","first-page":"311","article-title":"Follow-up examination schedule of postoperative HCC patients based on tumor volume doubling time","volume":"40","author":"S Okada","year":"1993","journal-title":"Hepatogastroenterology"},{"key":"pone.0238078.ref030","first-page":"45","article-title":"Growth kinetics of hepatocellular carcinoma","volume":"13","author":"M Yoshino","year":"1983","journal-title":"Jpn J Clin Oncol"},{"key":"pone.0238078.ref031","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1023\/A:1022505203786","article-title":"Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography","volume":"48","author":"K Kubota","year":"2003","journal-title":"Dig Dis Sci"},{"key":"pone.0238078.ref032","article-title":"Factors That Affect Efficacy Of Ultrasound Surveillance For Early-Stage Hepatocellular Carcinoma In Patients With Cirrhosis","author":"P Del Poggio","year":"2014","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"key":"pone.0238078.ref033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1756283X10385964","article-title":"Surveillance for hepatocellular carcinoma: in whom and how?","volume":"4","author":"HB El-Serag","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"pone.0238078.ref034","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1158\/1055-9965.EPI-11-1005","article-title":"Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"21","author":"AG Singal","year":"2012","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"pone.0238078.ref035","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/ajg.2014.213","article-title":"ACG clinical guideline: the diagnosis and management of focal liver lesions","volume":"109","author":"JA Marrero","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"pone.0238078.ref036","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"PJ Neumann","year":"2014","journal-title":"N Engl J Med"},{"key":"pone.0238078.ref037","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/hepr.12672","article-title":"Length time bias in surveillance for hepatocellular carcinoma and how to avoid it","volume":"46","author":"A Cucchetti","year":"2016","journal-title":"Hepatology Research"},{"key":"pone.0238078.ref038","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/hep.26739","article-title":"On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir","volume":"59","author":"GL Wong","year":"2014","journal-title":"Hepatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T17:32:43Z","timestamp":1598463163000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238078"}},"subtitle":[],"editor":[{"given":"Gianfranco D.","family":"Alpini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238078","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,8,26]]}}}